Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative disorder of the
central nervous system. The disease is characterised by inflammation with extensive …

The third part of this in-depth review series on the treatment of multiple sclerosis (MS) with
monoclonal antibodies covers the years 2010–2012. The natalizumab section gives a …

Background: Multiple sclerosis (MS) is a neurodegenerative disease caused by dysfunction
of the immune system that affects the central nervous system (CNS). It is characterized by …

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system
leading to demyelination and neurodegeneration. Basic and translational studies have …

The role of prolactin in MS pathogenesis was investigated. Prolactin levels were higher in
MS subjects both during remission and exacerbation compared to control subjects. Prolactin …

Objectives Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the
central nervous system characterized by a variable clinical course. Different pathogenic …

Growing evidence indicates that B cells play a key role in the pathogenesis of multiple
sclerosis (MS). B cells occupy distinct central nervous system (CNS) compartments in MS …

Plasmablasts are a highly differentiated, antibody secreting B cell subset whose prevalence
correlates with disease activity in Multiple Sclerosis (MS). For most patients experiencing …

Background/Aims: Multiple sclerosis (MS) causes significant neurological disability.
Experimental autoimmune encephalomyelitis (EAE) is an animal model of MS. Human bone …

Background: A large number of reports indicate the association of Epstein-Barr virus (EBV),
and Mycobacterium avium subsp. paratuberculosis (MAP) with multiple sclerosis (MS) …